Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
- Chamber
- House
- Introduced
- Jan 30, 2025
- Last action
- May 20, 2026 — REPORTED REFERRED TO RULES
- Session
- 2025-2026
- Momentum
- 59 · Moderate